ES2038687T3 - Procedimiento para la preparacion de nuevos derivados del pirrol. - Google Patents

Procedimiento para la preparacion de nuevos derivados del pirrol.

Info

Publication number
ES2038687T3
ES2038687T3 ES198787402708T ES87402708T ES2038687T3 ES 2038687 T3 ES2038687 T3 ES 2038687T3 ES 198787402708 T ES198787402708 T ES 198787402708T ES 87402708 T ES87402708 T ES 87402708T ES 2038687 T3 ES2038687 T3 ES 2038687T3
Authority
ES
Spain
Prior art keywords
alkyl
pyrrolidinyl
substituted
piperidyl
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787402708T
Other languages
English (en)
Inventor
Jean-Dominique Bourzat
Marc Capet
Claude Cotrel
Richard Labaudiniere
Philippe Pitchen
Gerard Roussel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Sante SA
Original Assignee
Rhone Poulenc Sante SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante SA filed Critical Rhone Poulenc Sante SA
Application granted granted Critical
Publication of ES2038687T3 publication Critical patent/ES2038687T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Rolls And Other Rotary Bodies (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)

Abstract

NUEVOS DERIVADOS DE FORMULA (I) EN LA QUE A FORMA CON EL CICLO PIRROL UN NUCLEO DE ISOINDOLINA CON SUSTITUYENTES QUE SE DETALLAN EN LA INVENCION. PREPARACION DE SUS SALES FARMACEUTICAMENTE ACEPTABLES Y LOS ISOMEROS OPTICOS DE LOS PRODUCTOS DE FORMULA (I). ESTOS COMPUESTOS SON UTILES COMO ANSIOLITICOS.
ES198787402708T 1986-12-02 1987-12-01 Procedimiento para la preparacion de nuevos derivados del pirrol. Expired - Lifetime ES2038687T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8616796A FR2607504B1 (fr) 1986-12-02 1986-12-02 Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2038687T3 true ES2038687T3 (es) 1993-08-01

Family

ID=9341443

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787402708T Expired - Lifetime ES2038687T3 (es) 1986-12-02 1987-12-01 Procedimiento para la preparacion de nuevos derivados del pirrol.

Country Status (23)

Country Link
EP (1) EP0271404B1 (es)
JP (1) JPS63154682A (es)
KR (1) KR880007517A (es)
AT (1) ATE66219T1 (es)
AU (1) AU594215B2 (es)
CA (1) CA1298295C (es)
DE (1) DE3772172D1 (es)
DK (1) DK169969B1 (es)
ES (1) ES2038687T3 (es)
FI (1) FI84723C (es)
FR (1) FR2607504B1 (es)
GR (1) GR3002490T3 (es)
HU (1) HU197573B (es)
IE (1) IE61089B1 (es)
IL (1) IL84658A (es)
MA (1) MA21118A1 (es)
MX (1) MX9558A (es)
NO (1) NO166037C (es)
NZ (1) NZ222752A (es)
OA (1) OA08696A (es)
PT (1) PT86261B (es)
SU (3) SU1616515A3 (es)
ZA (1) ZA879001B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
CZ309617B6 (cs) * 2019-04-05 2023-05-24 Ústav organické chemie a biochemie AV ČR, v. v. i 3α5ß-Neuroaktivní steroidy pro léčbu epilepsie a záchvatových onemocnění

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2101081B1 (es) * 1970-08-19 1974-01-11 Rhone Poulenc Sa
OA04285A (fr) * 1972-01-07 1979-12-31 Rhone Poulenc Sa Nouveaux dérivés de la pyrrolo (3,4-b) pyrazine et leur préparation.
AR207555A1 (es) * 1972-12-04 1976-10-15 Procedimiento para preparar aril-6-piperazinocarboniloxi-5 oxo-7 tetrahidro-2,3,6,7 ditiino(1,4)(2,3-c)pirroles
AR208414A1 (es) * 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
ZA756953B (en) * 1974-11-07 1976-10-27 Rhone Poulenc Ind 1,4-oxathiino(2,3-c)pyrrole derivatives
EP0091241B1 (en) * 1982-04-02 1988-12-28 Takeda Chemical Industries, Ltd. Condensed pyrrolinone derivatives, and their production
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS6169773A (ja) * 1984-09-14 1986-04-10 Takeda Chem Ind Ltd イソインドリノン誘導体
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
FR2607503B1 (fr) * 1986-12-02 1989-02-24 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2607506B1 (fr) * 1986-12-02 1989-01-06 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
FI875299A (fi) 1988-06-03
DK630487A (da) 1988-06-03
NZ222752A (en) 1989-10-27
HUT46007A (en) 1988-09-28
HU197573B (en) 1989-04-28
CA1298295C (fr) 1992-03-31
SU1657056A3 (ru) 1991-06-15
MX9558A (es) 1993-11-01
MA21118A1 (fr) 1988-07-01
ATE66219T1 (de) 1991-08-15
IE61089B1 (en) 1994-09-21
AU8193687A (en) 1988-06-02
NO875012D0 (no) 1987-12-01
FR2607504B1 (fr) 1989-01-27
EP0271404B1 (fr) 1991-08-14
IE873252L (en) 1988-06-02
DK169969B1 (da) 1995-04-18
ZA879001B (en) 1988-06-01
IL84658A (en) 1992-01-15
FI84723B (fi) 1991-09-30
PT86261A (fr) 1988-01-01
OA08696A (fr) 1989-03-31
KR880007517A (ko) 1988-08-27
GR3002490T3 (en) 1992-12-30
FI875299A0 (fi) 1987-12-01
FR2607504A1 (fr) 1988-06-03
DK630487D0 (da) 1987-12-01
NO875012L (no) 1988-06-03
SU1616515A3 (ru) 1990-12-23
JPS63154682A (ja) 1988-06-27
PT86261B (pt) 1990-11-07
EP0271404A2 (fr) 1988-06-15
DE3772172D1 (de) 1991-09-19
AU594215B2 (en) 1990-03-01
EP0271404A3 (en) 1989-04-05
FI84723C (fi) 1992-01-10
SU1685264A3 (ru) 1991-10-15
NO166037B (no) 1991-02-11
NO166037C (no) 1991-05-22
IL84658A0 (en) 1988-04-29

Similar Documents

Publication Publication Date Title
ES2029282T3 (es) Procedimiento para la preparacion de nuevos derivados del pirrol.
ES2038687T3 (es) Procedimiento para la preparacion de nuevos derivados del pirrol.
ES2038686T3 (es) Procedimiento para la preparacion de nuevos derivados del pirrol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 271404

Country of ref document: ES